Hatteras BioCapital

Hatteras BioCapital, now known as Hatteras Venture Partners, is a venture capital firm based in Durham, North Carolina, specializing in early-stage healthcare and life sciences investments. Founded in 2000, the firm focuses on biopharmaceuticals, medical devices, diagnostics, and health technology, with a particular emphasis on the Southeastern United States. Hatteras BioCapital provides strategic guidance, recruitment assistance, and business development support to its portfolio companies, helping them navigate the path from seed stage to commercialization. The firm manages over $900 million in capital across several funds and has a portfolio of over 100 companies. Notable portfolio successes include Kymera Therapeutics, G1 Therapeutics, and HistoSonics. The firm is recognized as a leader in the North Carolina life sciences ecosystem and maintains a robust North American investment footprint.